Press release
Global Indapamide Market Size, Share, Forecast, Analysis, Industry Report to 2026
Global indapamide market is estimated to grow significantly at a CAGR of over 2.0% during the forecast period. A significant rise in the incidences of high blood pressure (hypertension) and congestive heart failure is primarily contributing to the growth of the market. High blood pressure affects approximately a third of the adult population across the globe and is the most common cause of CVD-related mortalities. As per the data published by the American Health Association (AHA) in January 2018, 103 million US adults were suffering from high blood pressure, which is nearly half of all adults in the US.Get Free Sample Copy @ https://www.omrglobal.com/request-sample/indapamide-market
The global indapamide market is segmented on the basis of product and application. Based on the product, the market is bifurcated into 1.25 mg indapamide and 2.5 mg indapamide. Among these, the market for 1.25 mg medicine held a significant market share owing to the extensive application of the drug in treating high blood pressure or hypertension. Based on the application, the market is segmented into high blood pressure, heart failure, and others. The high blood pressure segment is projected to have a significant share in the market. Growing incidence of hypertension is contributing to the segmental growth as indapamide drugs are significantly used to treat hypertension while reducing the risk of developing serious heart conditions.
A Full Report of Global Indapamide Market is Available at: https://www.omrglobal.com/industry-reports/indapamide-market
Market Segmentation
Global Indapamide Market by Product
1.25 MG
2.5 MG
Global Indapamide Market by Application
High Blood Pressure
Heart Failure
Others
Segment by Region
North America
US
Canada
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Latin America
Middle East Africa
Company Profiles
ANI Pharmaceuticals, Inc.
Apotex Inc.
BioindustriaL.I.M. S.p.A.
Glenmark Pharmaceuticals Ltd.
Grupo Azevedos
Krka Group
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/indapamide-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Indapamide Market Size, Share, Forecast, Analysis, Industry Report to 2026 here
News-ID: 2203767 • Views: …
More Releases from Orion Market Research

Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033.
Road Marking Paint Market Overview
The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new…

Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period.
Outboard Boat Market Overview
The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including…

Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033.
Mobile Ticketing Market Overview
The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,…

Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033.
Metal Alloy Market Overview
The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in…
More Releases for Indapamide
Indapamide Market Increasing Demand, Growth Analysis and Future Outlook by 2031
The global indapamide market is estimated to grow significantly at a CAGR of over 2.0% during the forecast period. A significant rise in the incidences of high blood pressure (hypertension) and congestive heart failure is primarily contributing to the growth of the market. High blood pressure affects approximately a third of the adult population across the globe and is the most common cause of CVD-related mortalities. As per the data…
Asia-Pacific Indapamide Market
Asia-Pacific indapamide market is estimated to grow significantly at a CAGR of around 3.8% during the forecast period owing to the increasing prevalence of chronic disorders, including hypertension, CVD, and diabetes. The rising incidences of these diseases have been reported in several countries of Asia-Pacific, including China, India, and Singapore. For instance, in India, one in five young adults has high blood pressure, according to the data presented at the…
LAMEA Indapamide Market Size, Share, Impressive Industry Growth, Analysis Report …
The LAMEA indapamide market is estimated to grow significantly during the forecast period. The factors contributing to the growth of the indapamide market include rising cases of diabetes and hypertension among the population. According to the International Diabetes Federation (IDF), Brazil and Mexico are the two countries with a higher number of diabetes cases registered in the region. In Mexico, an estimated 12 million cases were registered in 2017. Additionally,…
Japan Indapamide MarketSize, Industry Trends, Share and Forecast 2020-2026
apan indapamide market is estimated to grow at a CAGR of around 1.7% during the forecast period. The growth is attributed to the rising number of hypertension and diabetes patients in the country. As per the IDF, in 2019, the total cases of diabetes in adults were 7.4 million, which accounted for nearly 7.9% of the total adult population in the country. The factors that are contributing to the increasing…
US Indapamide Market Size, Growth, Trends, Share, Forecast 2020-2026
US indapamide market is estimated to grow significantly during the forecast period. The significant prevalence of hypertension along with the CVD and high healthcare expenditure is primarily contributing to the market growth in the region. According to the Center for Medicare and Medicaid Services, in 2018, the US national healthcare expenditure was around $3.6 trillion showing a 4.4% increase in healthcare expenditure up from 3.9% in 2017. It is further…
North American Indapamide Market Trends, Growth, Analysis and Forecast - 2025
North American indapamide market is estimated to grow significantly at a CAGR of around 0.3% during the forecast period. The market is mainly growing due to the rising prevalence of hypertension and CVD such as heart strokes, blood pressure, arrhythmias among others. According to the Heart & Stroke Foundation in Canada (2017), 1.6 million fatalities occur every year due to stroke and at least 1.3 million Canadians live with heart…